Loitering with intent: New evidence for the role of BRAF mutations in the proliferation of melanocytic lesions

Journal of Investigative Dermatology

Volumn 123, Issue 4, 2004, Pages

  Smalley, Keiran S M ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P16; PROTEIN P19; RAF PROTEIN; RAS PROTEIN; RETINOBLASTOMA PROTEIN; VALINE;

AMINO ACID SUBSTITUTION; BRAF GENE; CELL CYCLE; GENE MUTATION; HUMAN; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MISSENSE MUTATION; NOTE; ONCOGENE; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION;

EID: 4644223115     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23430.x     Document Type: Note

References (11)

1. Daniotti M, Oggionni M, Ranzani T, et al: BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene June 14 [Epub ahead of print] 2004
2. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417:949-954, 2002
3. Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA: Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res 63:5198-5202, 2003
4. Houben R, Becker JC, Kappel A, et al: Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog 3:6, 2004
5. Kumar R, Angelini S, Snellman E, Hemminki K: BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122:342-348, 2004
6. Loewe R, Kittler H, Fischer G, Gae I, Wolff K, Petzelbauer P: BRAF kinase gene V599E mutation in growing melanocytic lesions. J Invest Dermatol 123:733-736, 2004
7. Maldonado JL, Fridlyand J, Patel H, et al: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-1890, 2003
8. Pollock PM, Harper UL, Hansen KS, et al: High frequency of BRAF mutations in nevi. Nat Genet 33:19-20, 2003
9. Smalley KSM: A pivotal role for ERK in malignant melanoma? Int J Cancer 104:527-532, 2003
10. Wan PT, Garnett MJ, Roe SM, et al: Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855-867, 2004
11. Wellbrock C, Ogilvie L, Hedley D: V599E B-RAF is an oncogene in melanocytes. Cancer Res 64:2338-2342, 2004